Routine antenatal anti-D prophylaxis for women who are rhesus D negative

  • Technology appraisal guidance
  • TA156
  • Published: 
Download guidance (PDF)

1 Recommendations

1.1

Routine antenatal anti-D prophylaxis (RAADP) is recommended as a treatment option for all pregnant women who are rhesus D (RhD) negative and who are not known to be sensitised to the RhD antigen.

1.2

When a decision has been made to give RAADP, the preparation with the lowest associated cost should be used. This cost should take into account the lowest acquisition cost available locally and costs associated with administration.